ZMYM3 May Promote Cell Proliferation in Small Cell Lung Carcinoma.

IF 1.6 4区 生物学 Q4 CELL BIOLOGY
Acta Histochemica Et Cytochemica Pub Date : 2021-10-29 Epub Date: 2021-10-02 DOI:10.1267/ahc.21-00012
Noritaka Kudo, Shinji Kudoh, Akira Matsuo, Yamato Motooka, Takaaki Ito
{"title":"ZMYM3 May Promote Cell Proliferation in Small Cell Lung Carcinoma.","authors":"Noritaka Kudo,&nbsp;Shinji Kudoh,&nbsp;Akira Matsuo,&nbsp;Yamato Motooka,&nbsp;Takaaki Ito","doi":"10.1267/ahc.21-00012","DOIUrl":null,"url":null,"abstract":"<p><p>Zinc finger, myeloproliferative, and mental retardation-type containing 3 (ZMYM3) is a highly conserved protein among vertebrates. Although it promotes DNA repair and moderate histone acetylation, the other functions of ZMYM3 remain unclear. We herein examined the physiological functions of ZMYM3 in human lung cancer using a <i>ZMYM3</i>-knockdown small cell lung cancer (SCLC) cell line. <i>ZMYM3</i>-knockdown SCLC cells grew slowly and the Ki-67 labeling index was lower in <i>ZMYM3</i>-knockdown cells than in mock cells. The subcutaneous tumors that formed after xenotransplantation into immunodeficient mice were slightly smaller in the <i>ZMYM3</i>-knockdown group than in the mock group. Furthermore, public RNA-sequencing data analyses showed similar RNA profiles between <i>ZMYM3</i> and some cell proliferation markers. These results indicate that ZMYM3 promotes cell proliferation in human lung carcinomas, particularly SCLC.</p>","PeriodicalId":6888,"journal":{"name":"Acta Histochemica Et Cytochemica","volume":null,"pages":null},"PeriodicalIF":1.6000,"publicationDate":"2021-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9a/c5/21-00012.PMC8569135.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Histochemica Et Cytochemica","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1267/ahc.21-00012","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/10/2 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Zinc finger, myeloproliferative, and mental retardation-type containing 3 (ZMYM3) is a highly conserved protein among vertebrates. Although it promotes DNA repair and moderate histone acetylation, the other functions of ZMYM3 remain unclear. We herein examined the physiological functions of ZMYM3 in human lung cancer using a ZMYM3-knockdown small cell lung cancer (SCLC) cell line. ZMYM3-knockdown SCLC cells grew slowly and the Ki-67 labeling index was lower in ZMYM3-knockdown cells than in mock cells. The subcutaneous tumors that formed after xenotransplantation into immunodeficient mice were slightly smaller in the ZMYM3-knockdown group than in the mock group. Furthermore, public RNA-sequencing data analyses showed similar RNA profiles between ZMYM3 and some cell proliferation markers. These results indicate that ZMYM3 promotes cell proliferation in human lung carcinomas, particularly SCLC.

Abstract Image

Abstract Image

Abstract Image

ZMYM3可能促进小细胞肺癌细胞增殖。
锌指、骨髓增生性和智力迟钝型含3(ZMYM3)是脊椎动物中高度保守的蛋白质。尽管它能促进DNA修复和适度的组蛋白乙酰化,但ZMYM3的其他功能仍不清楚。我们在此使用ZMYM3敲低的小细胞癌症(SCLC)细胞系来检测ZMYM3在人癌症中的生理功能。ZMYM3敲低的SCLC细胞生长缓慢,并且Ki-67标记指数在ZMYM3敲低的细胞中低于模拟细胞。ZMYM3敲低组在异种移植到免疫缺陷小鼠中后形成的皮下肿瘤比模拟组略小。此外,公开的RNA测序数据分析显示,ZMYM3和一些细胞增殖标志物之间的RNA图谱相似。这些结果表明ZMYM3促进人肺癌,特别是SCLC的细胞增殖。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Acta Histochemica Et Cytochemica
Acta Histochemica Et Cytochemica 生物-细胞生物学
CiteScore
3.50
自引率
8.30%
发文量
17
审稿时长
>12 weeks
期刊介绍: Acta Histochemica et Cytochemica is the official online journal of the Japan Society of Histochemistry and Cytochemistry. It is intended primarily for rapid publication of concise, original articles in the fields of histochemistry and cytochemistry. Manuscripts oriented towards methodological subjects that contain significant technical advances in these fields are also welcome. Manuscripts in English are accepted from investigators in any country, whether or not they are members of the Japan Society of Histochemistry and Cytochemistry. Manuscripts should be original work that has not been previously published and is not being considered for publication elsewhere, with the exception of abstracts. Manuscripts with essentially the same content as a paper that has been published or accepted, or is under consideration for publication, will not be considered. All submitted papers will be peer-reviewed by at least two referees selected by an appropriate Associate Editor. Acceptance is based on scientific significance, originality, and clarity. When required, a revised manuscript should be submitted within 3 months, otherwise it will be considered to be a new submission. The Editor-in-Chief will make all final decisions regarding acceptance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信